Vivian Ott

ZHAW Life Sciences und Facility Management
Fachgruppe Zellkulturtechnik
Grüentalstrasse 14
8820 Wädenswil

Arbeit an der ZHAW

Wissenschaftliche MItarbeiterin

Master of Science / Biotechnologie
Hochschule Anhalt
10 / 2018 - 06 / 2020
Bachelor of Science / Biotechnologie
Hochschule Anhalt
10 / 2015 - 09 / 2018

Ott, V., Ott, J., Mannone, A. D., & Eibl, R. (2025). Perfusion-based antibody production in the Ambr® 250 Modular. Chimia, 79(5), 330–338. https://doi.org/10.2533/chimia.2025.330
Ott, V., Ott, J., Eibl, D., & Eibl-Schindler, R. (2024). Scaling fed-batch and perfusion antibody production processes in geometrically dissimilar stirred bioreactors. Processes, 12(4), 806. https://doi.org/10.3390/pr12040806
Ott, J., Ott, V., Neubauer, P., Eibl, D., & Eibl-Schindler, R. (2024). Process intensification by inoculating antibody production bioreactors directly from cryovials . Chemie Ingenieur Technik, 96(4), 453–461. https://doi.org/10.1002/cite.202300189
Müller, J., Ott, V., Eibl, D., & Eibl-Schindler, R. (2022). Seed train intensification using an ultra-high cell density cell banking process. Processes, 10(5), 911. https://doi.org/10.3390/pr10050911
Ott, V., Müller, J., Schirmer, C., Weiss, N., Göhmann, R., Biewald, A., Michel, A., Eibl, D., & Eibl-Schindler, R. (2022). Qualification of a single‐use disk stack separator for cell separation in mammalian cell‐based antibody production. Chemie Ingenieur Technik, 94(12), 1936–1943. https://doi.org/10.1002/cite.202200096
Müller, J., Ott, V., Weiss, N., Neubauer, P., Eibl, D., & Eibl, R. (2022). Process intensification using a one‐step inoculum production and high‐seeded fed‐batch processes. Chemie Ingenieur Technik, 94(12), 1977–1984. https://doi.org/10.1002/cite.202200097

Ott, J., Ott, V., Brau, C., Beyer, S., Eibl, D., & Eibl-Schindler, R. (2024, June). Seed train intensification and production process automation for pilot-scale fed-batch and perfusion processes. 28th ESACT Meeting, Edinburgh, United Kingdom, 23-26 June 2024.
Schirmer, C., Ott, V., Müller, J., Göhmann, R., Biewald, A., Eibl-Schindler, R., & Eibl, D. (2022, June). Qualification of a single-use disk stack separator for modern mAb upstream processing at pilot scale. 27th ESACT Meeting, Lisbon, Portugal, 26-29 June 2022.
Müller, J., Ott, V., Weiss, N., Eibl, D., & Eibl-Schindler, R. (2022, June). Ultra-high cell density cell bank-based IgG production with CHO cells. 27th ESACT Meeting, Lisbon, Portugal, 26-29 June 2022.

Ott, V., & Grün, M. (2025, September). Accelerating and enabling consistency in bioprocessing scale-up. Technologies Network Biopharma Webinar, Online, September 2025.
Ott, V., & Brühlmann, B. (2025, September 3). Perfusion-based mAb production at 250 mL scale using ATF technology. GEN Genetic Engineering & Biotechnology News Webinar, Online, 3 September 2025.
Ott, V. (2025, June 17). ATF-based perfusion processes from 250 mL to 50 L scale. 5th BIOTECH Conference, Freiburg, Germany, 16-18 June 2025.
Ott, V. (2024, September 18). Maximizing performance and quality in fed-batch and perfusion-based IgG productions. Thermo Fisher Scientific Webinar, Online, 18 September 2024.
Ott, V. (2024, June 24). Scale-up from flask through 50 L bioreactor : the effect of GibcoTM Media on maximizing performance and quality in fed-batch and perfusion processes. 28th ESACT Meeting, Edinburgh, Scotland, 23-26 June 2024.
Ott, V., & Müller, J. (2023, May 10). Antibody production in lab and pilot scale single-use bioreactors. A3P Aseptic Processing, Milan, Italy, 10-11 May 2023.